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Abstract
Background: In the English NHS, Primary Care Trusts (PCTs) are required to commission health
services, to maximise the well-being of the population, subject to the available budget. There are
numerous techniques employed to make decisions, some more rational and transparent than
others. A weighted benefit score can be used to rank options but this does not take into account
value for money from investments.
Methods: We developed a weighted benefit score framework for use in an English PCT which
ranked options in order of 'cost-value' or 'cost per point of benefit'. Our method differs from
existing techniques by explicitly combining cost and a composite weighted benefit score into the
cost-value ratio.
Results: The technique proved readily workable, and was able to accommodate a wide variety of
data and competing criteria. Participants felt able to assign scores to proposed services, and
generate a ranked list, which provides a solid starting point for the PCT Board to discuss and make
funding decisions. Limitations included potential for criteria to be neither exhaustive nor mutually
exclusive and the lack of an interval property in the benefit score limiting the usefulness of a cost-
value ratio.
Conclusion: A technical approach to decision making is insufficient for making prioritisation
decisions, however our technique provides a very valuable, structured and informed starting point
for PCT decision making.
Background
The demand for health care will always exceed the capac-
ity of the available resources. Therefore decisions must be
made as to which treatments and services to commission
(purchase), in order to maximise the well-being of the
population, subject to the available budget.
The objective of the English National Health Service
(NHS) is not explicitly defined. However, the role of the
Department of Health is to "improve the health and well-
being of people in England" [1]. Primary Care Trusts
(PCTs) are responsible for commissioning an appropriate
basket of health care services to achieve this in their local
population (approximately 100,000 – 200,000). PCTs
can commission from a variety of care providers including
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tary sector and (in some cases) social services.
A PCT in the East of England previously made these deci-
sions by means of a 'cluster group' consisting largely of
chief executives, finance directors, and occasional clinical
input from both the PCT and the local major acute trust
(hospital). Both the PCT and the acute trust possessed a
list of desired purchases (e.g. new staff and new equip-
ment from the acute trust, and a mixture of health care
packages from the PCT), and agreement was reached as to
what was and would not be purchased through an infor-
mal process of arbitrage.
The key advantage of this system was that it was relatively
quick and cheap to operate. However mechanisms such as
this and others (for example needs assessment and 'histor-
ical allocation') suffer flaws as they are 'non-economic'.
That is, either they do not consider the relative health gain
from alternative courses of action (the opportunity cost)
or do not seek to optimise the well-being for the popula-
tion for the given budget (or both) [2]. The consequence
of either of these tools is inefficient allocation of scarce
resources, leading to a potential loss of well-being to the
population. Furthermore, the existing approach was sup-
plier rather than commissioner led, almost entirely input-
focussed with no consideration of outcomes, and little or
no evidence used to support the bids. The actual decision
making process was somewhat opaque making it difficult
to justify why and in whose interests a particular decision
was made.
The PCT Director of Public Health (JR) suggested initially
to the authors a basic framework incorporating epidemio-
logical, quality of life and "intervention" elements in a
matrix against which disease based areas could be tested.
The authors were consulted and requested by the PCT to
expand this basic framework and devise a tool that would
enable the "fair and equitable" commissioning of new
services. The tool would require bids for funds to be out-
come based and fully costed, making use of the literature
and other evidence in support. Comparison of the relative
value for money of bids could then be made, and funds
allocated to maximise the benefit ('well-being', health
gain and / or other objectives such as equity) for the mon-
ies available.
The assumed scenario was that a certain pool of growth
monies would be available from which competing bids
could be funded in ranked order. The tool would allow a
rational and defensible decision to be made as to which to
prioritise.
In this paper we describe the development of such a tool,
and discuss a number of its strengths and weaknesses,
including the results of some early testing.
Method
The method adopted in the study PCT is based on a multi-
criteria analysis approach. This generates a weighted ben-
efit score (WBS) which is combined with cost to generate
a cost-value ratio. A low cost-value ratio implies a better
value for money programme than one with a higher ratio.
There are seven steps:
1. Determine the benefit criteria
2. Weight the criteria
3. Score each programme against each criterion
4. Calculate weighted benefit score
5. Combine with cost data to generate cost-value ratio
6. Rank in order of cost-value ratio
7. Discussion of results.
1. Determine the benefit criteria
This is done at a brainstorming session, where 'desired'
characteristics of a health care programme are identified.
The criteria must, as far as is possible, be exhaustive (to
avoid underestimation of benefit), and mutually exclusive
(to avoid double counting). These criteria are essentially
an explicit definition of the aims of the PCT (and there-
fore should be consistent with the aims of the NHS as a
whole).
2. Weight the criteria
Some criteria may be considered more important than
others. Once the list of criteria has been determined, it is
necessary to weight them relative to one another. This is
done by allocating 100 percentage points amongst the cri-
teria.
Stages 1 and 2 define the benefits valuation framework.
The remaining stages relate to scoring individual pro-
grammes against the framework.
3. Score each programme against each criterion
Each programme submitted to this process is scored
against each criterion independently, on a scale of 0–10.
A score of 5 indicated no change compared with current
service provision in a particular criterion. A score greater
than this implied an improvement, and below, a deterio-
ration. A scale of 0–10 was chosen as it was hoped this
would allow enough scope for scorers to discriminatePage 2 of 9
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chosen to represent 'current performance' to accommo-
date programmes benefiting some criteria, but at the
expense of performance elsewhere (for example, improve-
ment in access and equity at the expense of some effective-
ness).
4. Calculate weighted benefit score
For each programme, the score for each criterion is multi-
plied by the weight on that criterion. The weighted scores
are added up across all criteria to obtain a weighted bene-
fit score for the entire programme.
5. Combine with cost data to generate cost-value ratio
The net financial impact (total cost of the proposal less
any savings from discontinued services and avoided NHS
activity) is divided by the weighted benefit score to gener-
ate the cost-value ratio.
6. Rank in order of cost-value
Programmes at the top of the list have the lowest cost-
value ratio. This means that they achieve the criteria more
efficiently that those with a higher cost-value ratio, and
therefore represent better value for money. Allocating
resources from the top of the list downwards then ensures
that those programmes achieving the stated aims of the
PCT most efficiently are prioritised above less efficient
ones.
7. Discussion of results
The ranked list of proposals by cost-value forms a recom-
mendation submitted to the PCT Board. The Board
reviews the list and may make changes from the recom-
mendation as it sees fit. This is a critical stage as, with any
prioritisation framework, there will be imperfections in
the mechanism which may generate apparently perverse
results. It is essential, however, that changes to the recom-
mended ranking are not arbitrary and must be justified
and documented, thus retaining transparency in the sys-
tem.
Results
Devising the framework
The framework for calculating benefit scores was devised
and tested at a workshop held in October 2003. The day
was split into three sessions (defining the criteria, weight-
Table 1: Criteria definitions (alphabetically)
Criterion Definition
Access & equity • Does this proposal increase or improve access to services for the target population?
• Does this proposal have any impact on access to services for other populations or other NHS agencies 
(positive or negative)?
• Is this a locally based service?
• Is this service available to all who need it?
• Is this patient-centred healthcare? Do they get a say in the delivery of their care? Is there demonstrable 
'patient & public involvement'?
• Does the proposal enable treatment in an appropriate environment?
• Does the proposal raise the profile of an important but currently low profile disease / condition?
Effectiveness • Is the proposal proven to work? (what evidence is there for it working?)
• What is the quality / grade of the evidence? (e.g. well conducted randomised controlled trial versus 
expert opinion).
• What is the balance of risk and benefit to the patient?
• Will the proposal result in enough activity to maintain quality? (clinical governance issues)
Local & National Priorities • How far towards meeting an explicit national or local target does this proposal go (for example, National 
Institute for Clinical Excellence, National Service Frameworks, Local Development Plans etc)?
Need • What is the prevalence / incidence of the disease or condition this proposal is intended to treat?
• What is the current mortality or morbidity associated with this disease/condition? (note this should take 
into account the impact of existing treatments)
• Does this proposal meet an identified health need (either local or national)?
• Does it meet public expectations / does it meet a local health want?
Prevention • Does the programme focus or put greater emphasis on prevention of ill health? (For example through 
health promotion, screening/ immunisation or reduction in future morbidity.)
Process • Is the proposal achievable within a realistic timescale?
• Does the proposal involve multi-agency working / partnership working across different areas of the NHS 
(and wider bodies)?
• Is the proposal acceptable politically?
Quality of life • What impact does the intervention have on different domains of quality of life (e.g. disability reduction, 
increase in independence, pain reduction, whether it allows a patient to play active role in society, social 
relationships, etc)?
• What is the potential QALY (Quality Adjusted Life Years) gain from the intervention?
• Does the proposal decrease (future) care needs for the patient, carer or family?
• What evidence is there for the patient experience / satisfaction?Page 3 of 9
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mock proposals). The test session demonstrated the feasi-
bility of the framework.
Around 20 representatives from across the local health
economy, including NHS clinicians, PCT and acute trust
managers, social services and the voluntary sector
attended the workshop, and were split into 5 mixed
groups for the day. Sessions 1 and 2 generated the evalua-
tion framework comprising seven criteria (Table 1), each
weighted relative to one another (Figure 1).
The weighted criteria can be grouped into four broad 'lev-
els of importance'. Need and quality of life were consid-
ered the most important, with just under 20% of the total
weighting each. Prevention and effectiveness were consid-
ered of similar importance at 15% each. The third group-
ing consisted of priorities and access & equity issues, and
finally process (referring to the feasibility, speed of imple-
mentation and integrated working) was considered the
least important of the criteria. Each of the five groups
weighted the criteria independently and averages were
taken to arrive at the percentages. There was some varia-
tion between the groups in weighting each criterion and
the impact of this is investigated in the sensitivity analysis.
Testing the framework
The final session of the day was a mock scoring round to
test the feasibility of the framework. This comprised four
fictitious proposals to be scored against the criteria, and
was an important exercise to enable participants to see the
complete process. The four proposals comprised an acute
service development (W), a preventative programme (X),
a screening programme (Y) and a mental health pro-
gramme (Z).
Criteria and weightsFigu e 1
Criteria and weights. Mean weightings of the criteria relative to one another.
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due to time limitations, each group scored only one or
two. For each proposal, weighted average scores were cal-
culated from the 5 group scores against each criterion
(Table 2).
The highest scoring programme was proposal Y (screen-
ing), followed by W (acute service), X (preventative) and
finally Z (mental health). This ranking though only takes
into account benefit score, and not the cost or resources
required. When the net financial impact is divided by the
weighted benefit score (to calculate the cost-value ratio),
the ranking changes to Y, X, W, Z (Table 3).
Bid Y was ranked first, as not only was this the highest
scoring programme, but it also resulted in a net cost sav-
ing, therefore representing a good investment. Bids X, W
and Z followed in order of cost per point. This list would
be the recommended funding order for the programmes,
commencing with bid Y, then X and so on until all funds
had been allocated.
Sensitivity analysis
As only one or two groups scored each proposal, it was not
possible to analyse any variance in proposal scores. How-
ever, each group did weight the criteria independently.
Most of the groups were broadly consistent with each
other in their criteria weightings, with least variation
around the 'access and equity' and 'need' criteria (Figure
2). However, there are a couple of exceptions, for example
one group (the 'green' group) gave quality of life a much
higher weighting than the other groups and relatively
equal weighting to all other criteria, whilst the 'orange'
group focussed highly on prevention, and gave a zero
weighting to process.
We performed a sensitivity analysis by substituting mean
criteria weightings for each individual group's, to investi-
gate whether there was any effect on the final ranking of
the four proposals.
Substituting individual group weightings for the average
had remarkably little effect on the ranking of the four
mock proposals by benefit score alone, with the ordering
only changing in the case of the orange group. This group
would have ranked proposal X slightly higher than pro-
posal W. This was because the orange group put a great
deal of weight on the 'prevention' criterion, and proposal
X was itself a programme focussing on prevention of ill
health. However, the changes do not affect the cost-value
ratios sufficiently to change the ranking (Figure 3).
Discussion
Similar techniques to prioritising scarce resources have
been adopted elsewhere in both the health and non-
health sectors. [3-13] Some of these rank options by a
weighted benefit score alone [3,5,8], or used no explicit
means of prioritising the options. [7,12] The limitation of
these methods is that they do not consider the relative
value for money of each of the options for service expan-
sion, i.e. the benefit gained for each pound spent. Services
are prioritised solely in order of benefit score, without tak-
Table 2: Raw scores by programme
Criteria Weighted 
score
Effectiveness Quality of Life Access/Equity Need Priorities Prevention Process
Weights 0.15 0.182 0.118 0.198 0.126 0.156 0.07
Programme
W (acute service) 6 7.6 8.6 6.4 4.8 4.6 4.6 6.21
X (preventative) 2 7 4 5 4 10 5 5.45
Y (screening) 7 7 9 9 9 6 9 7.87
Z (mental health) 1.3 2.3 3.3 2.7 7 3.7 0.7 3.05
Table 3: Cost-value ratio ranking
Bid Net Cost Impact Score Cost/Point
Y (screening) -£7,780,000 7.87 -£988,564
X (preventative) £21,600 5.45 £3,693
W (acute service) £100,000 6.21 £16.585
Z (mental health) £217,000 3.05 £71,225Page 5 of 9
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of benefit / outcome. Therefore overall outcome may not
be maximised subject to the available budget.
Our method differed from these by dividing cost into the
weighted benefit score to rank in order of 'cost-value'. An
alternative method of combining costs and benefits data
is the 'prioritisation scoring index' [9]. Here the final rank-
ing is the average of cost and benefit rank. This ensures
low cost / high benefit programmes are ranked above high
cost / low benefit, but there is a risk of inconsistent results
in the middle of the table.
The framework developed most resembles a cost per
QALY (Quality Adjusted Life Year) league table [14]. In
this case, the outcome of a particular health care pro-
gramme is measured in QALYs, and ranking in order of
incremental cost per QALY gained ensures those at the top
of the list, representing best value for money (i.e. greatest
gain per pound spent), are funded first. This will maxim-
ise the QALYs gained for the population subject to the
budget constraint.
However there are limitations with using the QALY
approach: QALYs are sensitive to the quality of life tool
used to value them [15], and may not capture all dimen-
sions of quality of life relevant to patients. Most impor-
tantly, this method assumes that the sole objective of the
health care system is to maximise QALYs gained [16].
Wider societal objectives such as access to services, equity
and exogenously determined national priorities are not
captured by the QALY (although it is postulated that
equity weights can be applied to QALYs [17]). Our tool
has the advantages of a league table approach (ranking in
order of cost-value and therefore ensuring technical effi-
Variance in criteria weightsFigure 2
Variance in criteria weights. Variation in criteria weightings between groups.
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include a comprehensive range of objectives.
A limitation of our method is that is does not consider
(in)divisibilities within programmes, and the impact of
returns to scale. The implicit assumption is that the 'cost'
for a point of benefit is the same, no matter what the scale
of the programme. In reality this is unlikely to be so: a
scaled down programme may deliver marginally greater
benefits, or conversely (due to indivisibilities) may deliver
no benefits at all. However, these would be difficult to
measure and add a great deal of additional work and com-
plexity to the process.
The criteria used in the framework should be exhaustive
and mutually exclusive. There is a risk in our framework
that this may not have been so. For example, there may
have been overlap between the definitions of 'effective-
ness' and 'quality of life'. However, workshop participants
were insistent that to them, these were very different con-
cepts (effectiveness relating to clinical measures of
response, whilst quality of life was more patient
focussed). We felt that for the participants to retain own-
ership of their framework, it was necessary to allow them
to have final say as to the criteria and their definitions.
As stated previously, it is desirable to present results in the
form of a 'cost-value' ratio to ensure the most efficient
programmes are prioritised. However, this results in a
biased ratio as the weighted benefit score does not possess
an interval property (the difference between a score of 6
and 8 is not necessarily the same as the difference between
a score of 8 and 10). A possible solution is to simply incor-
porate some measure of resource use (or rather, cost-effec-
Sensitivity analysisFigure 3
Sensitivity analysis. Changes in the cost-value ratios from using mean criteria weights versus each individual group's. The 
ranking is from lowest to highest cost-value ratio. Note that the lines do not cross meaning the ranked order does not change 
no matter which set of weights are used. This suggests the ranking is robust to variations in criteria weightings.
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in order of weighted benefit score. This though risks inef-
ficient programmes being prioritised. We decided to use a
"cost per patient affected" as the numerator in the cost-
value ratio in future implementation: with all costs meas-
ured on the per patient level, the cost-value ratio becomes
a fairer comparator. This technique has been employed
before [4], and partly solves the problem, but this (and
the other limitations described) underlines the impor-
tance of using the tool as a starting point for discussions
rather than the decision itself.
In essence, we have developed a semi-technical method of
solving the resource allocation problem. Attempts have
been made in the past, most notably in Oregon [18] to
make decisions based solely against a set of rational rules.
These have run into trouble for both practical (data avail-
ability) and conceptual reasons (differing interpretation
of the evidence and disagreement as to the purpose of a
public healthcare system) [19], and there is concern that
overly technical approaches appear more scientific and
transparent than they really are [20]. We have emphasised
that the rankings generated by our tool should be seen as
a starting point from which meaningful discussions can
take place to decide priorities, and are not the solution
itself. A structured tool such as this provides an essential
'rational' starting point for these discussions (although
rationality is bounded within the information set availa-
ble). Evaluation of its success must be in terms of whether
or not a 'better' basket of health services is commissioned
as a result of the process compared to without it, not
whether the 'perfect' basket could have been commis-
sioned.
Most participants at the workshop felt able to assign a
score for each programme against each criterion, and did
not feel the framework was lacking any important criteria.
However, a number of issues arose during development
which required clarification prior to implementation.
These were firstly, a practical limitation of testing the tool
prior to finalising criteria definitions. The full criteria def-
initions (Table 1) were not finalised until after the initial
workshop. This may have resulted in different interpreta-
tions of the same criterion. Secondly, as the focus of the
workshops was on developing the benefits framework, the
costs of the example proposals were simply presented as
net financial impacts, with no greater detail. Thirdly, there
is a risk of 'clustering' of scores, and thus a failure to dif-
ferentiate between programmes. Our sample size in the
test run was too small to detect this, but will be monitored
as we implement and evaluate the framework.
As a result of these issues and from discussions at further
workshops, the finalised criteria definitions list was
devised, and that in implementing this tool:
• The three constituencies of patients, managerial /
finance and clinicians would be represented by three sep-
arate groups who would score proposals independently.
Representatives of each of these groups would then meet
in a plenary session to agree on final scorings for propos-
als. This should ensure all 3 groups have equal say in
deciding priorities.
• The cost perspective would be societal (including NHS,
other agency and patient out of pocket costs), and the
time horizon for costs and benefits would be limited to
three years.
Limiting the time horizon has the obvious disadvantage
of biasing against interventions whose benefits would not
be seen within that time span. This would be particularly
the case with preventative public health interventions, but
it was necessary to compromise between accuracy of data
and the risk of underestimating future benefits. During
the testing phase of the tool, the preventative programme
(X) was ranked highest in cost-value ratio, but only third
by benefit score alone. It is therefore not clear whether it
would fare so well with a limited time horizon. These
issues underline the importance of the PCT Board review-
ing the results generated by the process.
Conclusion
As demands for health care will always outstrip the
resources available, prioritisation decisions have to be
made in order to maximise the objectives of the PCT sub-
ject to the funding available. An explicit, open and trans-
parent prioritisation procedure making use of the
evidence base with a clear set of goals and objectives is
more defensible than implicit decision making tech-
niques.
There are practical restrictions in implementing any struc-
tured, purely technical approach to priority setting (for
example data availability, uncertainty and existence of
competing goals in the PCT). Consequently any prag-
matic scheme will necessarily stray from a theoretic ideal.
Furthermore, attempts to correct for subsequent inconsist-
encies can introduce flaws of their own. Discussion of the
results of this framework is therefore essential to confirm
priorities.
The benefit scores will be assessed individually by each of
three groups (clinical, public, and managerial), before
confirmation at a plenary session. Issues arising relating to
the knowledge and different experiences of each of these
groups and the training and degree of guidance required,
e.g. for members of the public group, are being addressed.
However, this weakness of having three groups is also a
strength: a wide range of individuals from differing ofPage 8 of 9
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posed programmes of care.
Ultimately, no technical formula can make complex deci-
sions: it can only inform them. Therefore judgement is
required: the benefit of this approach is that it forces deci-
sion makers to consider why it is they feel a project should
be accepted or rejected, and provides a starting point for
discussions upon which to make final funding decisions.
Once the process is complete, there will be programmes of
care the PCT feels would be of benefit, but fall 'below the
line' in the ranked list. The next step is to examine existing
expenditure, and consider whether the gains from these
new programmes would outweigh losses from potential
disinvestments. This is consistent with a Programme
Budgeting and Marginal Analysis (PBMA) approach, and
this framework would assist in identifying the 'least worst'
options from which to disinvest.
The tool is now in use across the PCT and will be evalu-
ated and refined after its first year of operation. By involv-
ing a wide constituency in decision making, and explicitly
taking into account 'equity' as one of the criteria, we aim
to make decision making within the PCT, if not 'fair and
equitable' then at least 'fairer' and 'more equitable'.
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